speb/financial-data huggingface dataset:
Stock screener scorecard for AGNCN (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.072638409033452%
Capitalized R&D asset: 0
Free cash flow margin: 34.891485809682806%
Revenue growth: 84.68653648509765%
Rule of 40 score: 119.57802229478045
Market cap: 11534864480 (Large Cap ($10B-$200B))
P/E ratio: 6.907104479041917
Debt to equity: 0.004518679899943517
Free cash flow (dilution adjusted): 627000000
Net income: 1670000000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for BIVI (annual, report date 2025-06-30)
Altman Z-score: -8.19058297756509 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -93.64347544963518%
Capitalized R&D asset: 35732833.97
ROCI (R&D adjusted): -55.77645244159643%
Rule of 40 score: 0
Market cap: 69762010.75 (Micro Cap ($50M-$300M))
Debt to equity: 0.01840386472007
Free cash flow (dilution adjusted): -21497141
Operating income: -18066200
Net income: -17542120
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BMA (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7972430873130.233 (Mega Cap (>= $200B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CVU (annual, report date 2025-12-31)
Altman Z-score: 0.9546269439825408 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.0314011552108537%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3377331458174183%
Free cash flow margin: -8.766221203380942%
Revenue growth: -14.574377855121403%
Rule of 40 score: -23.340599058502345
Market cap: 52310289.24 (Micro Cap ($50M-$300M))
Debt to equity: 1.086485967259069
Free cash flow (dilution adjusted): -6071671
Operating income: -176382
Net income: -843361
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DOGZ (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 98637.8916150453
Rule of 40 score: 0
Market cap: 639873680.9039999 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ING (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.466857593491886%
Capitalized R&D asset: 0
Free cash flow margin: -29.389162991747803%
Revenue growth: 14.688825250770709%
Rule of 40 score: -14.700337740977094
Market cap: 65966955716.158 (Large Cap ($10B-$200B))
P/E ratio: 9.991965422017266
Debt to equity: 3.5173395089592323
Free cash flow (dilution adjusted): -7918823529.411765
Net income: 7767058823.529412
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for INTR (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 19.99200800427222%
Capitalized R&D asset: 0
Free cash flow margin: 85.22304295068002%
Revenue growth: 48.02819986619369%
Rule of 40 score: 133.2512428168737
Market cap: 14942182464.7848 (Large Cap ($10B-$200B))
P/E ratio: 10.693450155536773
Debt to equity: 1.4493643871689315
Free cash flow (dilution adjusted): 1306484489.0510948
Net income: 254985583.9416058
Long score: 4 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for JTC.L (annual, report date 2024-12-31)
Altman Z-score: 0.5386946367340684 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.869652001914757%
Free cash flow margin: 10.521869259258047%
Revenue growth: 17.140192860472343%
Rule of 40 score: 27.66206211973039
Market cap: 16730598.384399999 (Nano Cap (< $50M))
Debt to equity: 0.6047185430463576
Free cash flow (dilution adjusted): 40165000
Operating income: 31772500
Net income: -9070000
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for KIO (annual, report date 2025-10-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.4727471083777335%
Capitalized R&D asset: 0
Free cash flow margin: 279.0341126868532%
Revenue growth: -62.04207524660285%
Rule of 40 score: 216.99203744025033
Market cap: 450836815 (Small Cap ($300M-$2B))
P/E ratio: 19.360021256495042
Debt to equity: 0.3321284106929522
Free cash flow (dilution adjusted): 72800000
Net income: 23287000
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KLRS (annual, report date 2025-12-31)
Altman Z-score: 0.7913233797737314 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -55.35184104346943%
Capitalized R&D asset: 64794450
ROCI (R&D adjusted): -25.204856976448358%
Rule of 40 score: 0
Market cap: 200806826.32 (Micro Cap ($50M-$300M))
Debt to equity: 0.018372370391047277
Free cash flow (dilution adjusted): -40506000
Operating income: -46152000
Net income: -43438000
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for NOU.TO (annual, report date 2025-12-31)
Altman Z-score: 2.579212167800174 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -139.655345155796%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -71.87793540306846%
Rule of 40 score: 0
Market cap: 1102533005.5 (Small Cap ($300M-$2B))
Debt to equity: 0.242811341548943
Free cash flow (dilution adjusted): -43897080.291970804
Operating income: -43566423.35766423
Net income: -76771532.84671532
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for NRGV (annual, report date 2025-12-31)
Altman Z-score: -0.24765035214930975 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -234.70294187185462%
Capitalized R&D asset: 44298650
ROCI (R&D adjusted): -44.57000107290377%
Rosenberg metric: 1.607869533443594
Free cash flow margin: -41.64903201732205%
Revenue growth: 340.8558626810104%
Rule of 40 score: 299.2068306636884
Market cap: 835513034.7 (Small Cap ($300M-$2B))
Debt to equity: 1.0915184616773494
Free cash flow (dilution adjusted): -84827000
Operating income: -74367000
Net income: -103611000
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for PRL.TO (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 37.49345725993257%
Capitalized R&D asset: 0
Free cash flow margin: -7.026101144235912%
Revenue growth: 39.38803661693773%
Rule of 40 score: 32.36193547270182
Market cap: 961213031.46 (Small Cap ($300M-$2B))
P/E ratio: 16.149331364414014
Debt to equity: 1.2981056796911308
Free cash flow (dilution adjusted): -28491602.189781018
Net income: 43445473.72262774
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for PXS (annual, report date 2025-12-31)
Altman Z-score: 0.7150810703759105 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.320092475830181%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.2756215821285446%
Free cash flow margin: 33.107657588346925%
Revenue growth: -14.55457228485279%
Rule of 40 score: 18.553085303494136
Market cap: 24456314.869 (Nano Cap (< $50M))
P/E ratio: 12.264952291374122
Debt to equity: 0.8605075501287122
Free cash flow (dilution adjusted): 15188235.294117648
Operating income: 6962352.94117647
Net income: 2345882.3529411764
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SPAI (annual, report date 2025-12-31)
Altman Z-score: 33.43674785161184 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -82.86814102512464%
Capitalized R&D asset: 578062.39
ROCI (R&D adjusted): -73.78004273207046%
Rosenberg metric: -7.789669366617979
Free cash flow margin: -2202.9409195277253%
Revenue growth: -72.03175580796044%
Rule of 40 score: -2274.972675335686
Market cap: 85774278.72 (Micro Cap ($50M-$300M))
Debt to equity: 0.011407509832498289
Free cash flow (dilution adjusted): -13364824
Operating income: -13714661
Net income: -14322779
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SPMC.V (annual, report date 2024-12-31)
Altman Z-score: 165.3630068123591 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.83514492753623%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.416666666666668%
Rule of 40 score: 0
Market cap: 31113009 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -2445454.5454545454
Operating income: -1190209.7902097902
Net income: -1029370.6293706294
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for STUD.V (annual, report date 2025-12-31)
Altman Z-score: 7.0317957382830585 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.34615464387546%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.7954094785785%
Rule of 40 score: 0
Market cap: 48042409.6 (Nano Cap (< $50M))
Debt to equity: 0.0006662184148049319
Free cash flow (dilution adjusted): -2976056.204379562
Operating income: -2507481.751824817
Net income: -1456664.2335766421
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for TECX (annual, report date 2025-12-31)
Altman Z-score: 23.206215847785014 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -29.011375527694778%
Capitalized R&D asset: 103401660
ROCI (R&D adjusted): -19.11641354659757%
Rule of 40 score: 0
Market cap: 393611219.96 (Small Cap ($300M-$2B))
Debt to equity: 0.005077010611588794
Free cash flow (dilution adjusted): -70783000
Operating income: -84036000
Net income: -74151000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TMQ.TO (annual, report date 2025-11-30)
Altman Z-score: 17.349860087917307 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -34.03211382441327%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.600389722282613%
Rule of 40 score: 0
Market cap: 1027836552.05 (Small Cap ($300M-$2B))
Debt to equity: 0.0008942886377003087
Free cash flow (dilution adjusted): -4702857.142857144
Operating income: -6742142.857142857
Net income: -30172142.85714286
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for UU2.DE (annual, report date 2025-12-31)
Altman Z-score: 1.709230333606222 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -90.90044818688034%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.700519440383221%
Free cash flow margin: 9.270730095804426%
Revenue growth: 18.665163914343115%
Rule of 40 score: 27.935894010147543
Market cap: 166269935943.37646 (Large Cap ($10B-$200B))
P/E ratio: 27.98215010827608
Debt to equity: 0.2436709889181372
Free cash flow (dilution adjusted): 2245000000
Operating income: 7909000000
Net income: 5942000000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for VHI (annual, report date 2025-12-31)
Altman Z-score: 1.5666329108788903 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.7741639945029776%
Free cash flow margin: -3.9528165623495424%
Revenue growth: -1.3207905739262638%
Rule of 40 score: -5.273607136275806
Market cap: 337080309.63 (Small Cap ($300M-$2B))
Debt to equity: 0.44848573733225783
Free cash flow (dilution adjusted): -82100000
Operating income: -16900000
Net income: -54900000
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for XRX (annual, report date 2025-12-31)
Altman Z-score: 1.1064433065558779 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 433540000
ROCI (R&D adjusted): -0.6065310122149659%
Rosenberg metric: -0.3089005235602094
Free cash flow margin: 1.2532042153232696%
Revenue growth: 12.875743449606173%
Rule of 40 score: 14.128947664929441
Market cap: 302100901.41 (Small Cap ($300M-$2B))
Debt to equity: 6.7964338781575035
Free cash flow (dilution adjusted): 88000000
Operating income: -56000000
Net income: -1029000000
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for XZO (annual, report date 2025-12-31)
Altman Z-score: 16.70180070210634 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 32.59376131195014%
Capitalized R&D asset: 8830000
ROCI (R&D adjusted): 41.10468142432871%
Free cash flow margin: 43.69895842934833%
Rule of 40 score: 43.69895842934833
Market cap: 2204771927.5 (Mid Cap ($2B-$10B))
P/E ratio: 26.64409149959516
Debt to equity: 0.028506114354963093
Free cash flow (dilution adjusted): 94818000
Operating income: 105990000
Net income: 82749000
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for ZED.L (annual, report date 2024-11-30)
Altman Z-score: -5.336128122328469 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 716293.8517179022
ROCI (R&D adjusted): -80.00346619009603%
Rosenberg metric: -0.3643564356435644
Free cash flow margin: -1088.235294117647%
Revenue growth: -75.53956834532374%
Rule of 40 score: -1163.7748624629708
Market cap: 37147.5973 (Nano Cap (< $50M))
Debt to equity: 0.011348464619492656
Free cash flow (dilution adjusted): -936708.8607594937
Operating income: -1824050.6329113923
Net income: -1567088.6075949366
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for 1253.HK (annual, report date 2025-12-31)
Altman Z-score: -0.784047650334471 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.258646336140223%
Free cash flow margin: 82.49606483807229%
Revenue growth: 150.26057005080511%
Rule of 40 score: 232.7566348888774
Market cap: 59203412 (Micro Cap ($50M-$300M))
Debt to equity: 25.555300000000003
Free cash flow (dilution adjusted): 7037857.142857143
Operating income: -2871142.8571428573
Net income: -20154428.57142857
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1253.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 59203412 (Micro Cap ($50M-$300M))
Debt to equity: 25.555300000000003
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 1284.HK (annual, report date 2025-12-31)
Altman Z-score: 3.791759278765241 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.33537620266428%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.960150527518314%
Free cash flow margin: 16.20658949243099%
Revenue growth: -8.65132647713188%
Rule of 40 score: 7.55526301529911
Market cap: 255000000 (Micro Cap ($50M-$300M))
P/E ratio: 2.249357326478149
Debt to equity: 0.22089999999999999
Free cash flow (dilution adjusted): 3953470.437017995
Operating income: 3718380.4627249357
Net income: 1637917.737789203
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 1284.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 255000000 (Micro Cap ($50M-$300M))
P/E ratio: 2.249357326478149
Debt to equity: 0.22089999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2237.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 332800000 (Small Cap ($300M-$2B))
Debt to equity: 0.2155
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2237.HK (annual, report date 2025-12-31)
Altman Z-score: 2.307149373739221 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.317453095308192%
Capitalized R&D asset: 3306902.9114749767
ROCI (R&D adjusted): 0.3375274636084917%
Rosenberg metric: 0.48572871175459986
Free cash flow margin: 6.783462816186665%
Revenue growth: 12.009849517909439%
Rule of 40 score: 18.793312334096104
Market cap: 332800000 (Small Cap ($300M-$2B))
P/E ratio: 108.592826689098
Debt to equity: 0.2155
Free cash flow (dilution adjusted): 1481857.142857143
Operating income: 522571.4285714286
Net income: 700714.2857142857
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2310.HK (annual, report date 2025-12-31)
Altman Z-score: -3.680157996246832 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: 0.18518676554672764%
Revenue growth: 5.508204518607031%
Rule of 40 score: 5.693391284153758
Market cap: 193439264 (Micro Cap ($50M-$300M))
Debt to equity: -2.764865903781899
Free cash flow (dilution adjusted): 27892.030848329046
Operating income: -601542.4164524422
Net income: -179820.05141388174
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 2310.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 193439264 (Micro Cap ($50M-$300M))
Debt to equity: -2.764865903781899
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2363.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 62288344 (Micro Cap ($50M-$300M))
Debt to equity: -0.04912490055688147
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 2363.HK (annual, report date 2025-12-31)
Altman Z-score: -6.736051750039048 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -20.930260286875956%
Free cash flow margin: -5.248211542341056%
Revenue growth: -10.218684049232978%
Rule of 40 score: -15.466895591574033
Market cap: 62288344 (Micro Cap ($50M-$300M))
Debt to equity: -0.04912490055688147
Free cash flow (dilution adjusted): -434704.3701799486
Operating income: -2256298.2005141387
Net income: -3059125.964010283
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for 2735.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8827445248 (Mid Cap ($2B-$10B))
P/E ratio: 0.06862595193413744
Debt to equity: 0.1503
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2810.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 352552091648 (Mega Cap (>= $200B))
P/E ratio: 0.23976024793018255
Debt to equity: 0.057999999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2930.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 16733179904 (Large Cap ($10B-$200B))
P/E ratio: 0.1572807195353852
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3420.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11922451456 (Large Cap ($10B-$200B))
P/E ratio: 0.06877429187343923
Debt to equity: 0.039
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3699.HK (annual, report date 2025-12-31)
Altman Z-score: 1.3964589432378631 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.088352207303275%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3709676079941138%
Free cash flow margin: 29.0973181918324%
Revenue growth: 8.47451059662388%
Rule of 40 score: 37.57182878845628
Market cap: 172146000 (Micro Cap ($50M-$300M))
P/E ratio: 0.9768637532133675
Debt to equity: 0.0025
Free cash flow (dilution adjusted): 1867352.1850899742
Operating income: 2121979.4344473006
Net income: 2510025.706940874
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 3699.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 172146000 (Micro Cap ($50M-$300M))
P/E ratio: 0.9768637532133675
Debt to equity: 0.0025
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3907.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3046925568 (Mid Cap ($2B-$10B))
Debt to equity: 0.1524
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4242.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5116559360 (Mid Cap ($2B-$10B))
P/E ratio: 0.019716253297064258
Debt to equity: 0.4264
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4242.T (annual, report date 2026-03-31)
Altman Z-score: 2.121216132647773 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.097907682478834%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.416970049997573%
Free cash flow margin: -1.3694336620295584%
Revenue growth: -12.345055359470724%
Rule of 40 score: -13.714489021500283
Market cap: 5116559360 (Mid Cap ($2B-$10B))
P/E ratio: 0.019716253297064258
Debt to equity: 0.4264
Free cash flow (dilution adjusted): -3553553.5535535533
Operating income: 13425925.925925925
Net income: 13526026.026026025
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 5946.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 69975719936 (Large Cap ($10B-$200B))
P/E ratio: 0.19289406594094094
Debt to equity: 0.0002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6046.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2308821248 (Mid Cap ($2B-$10B))
Debt to equity: 0.12990000000000002
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6360.T (annual, report date 2026-03-31)
Altman Z-score: 2.138128135827999 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.109744924844344%
Capitalized R&D asset: 1671837.434035044
ROCI (R&D adjusted): 5.374099586284861%
Rosenberg metric: -8.475137216055694
Free cash flow margin: 21.454459056605018%
Revenue growth: -29.610862098026864%
Rule of 40 score: -8.156403041421846
Market cap: 6280492544 (Mid Cap ($2B-$10B))
P/E ratio: 0.04155050124178317
Debt to equity: 0.8299
Free cash flow (dilution adjusted): 13010379.129129129
Operating income: 4186830.5805805805
Net income: 5057932.932932933
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 6360.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6280492544 (Mid Cap ($2B-$10B))
P/E ratio: 0.04155050124178317
Debt to equity: 0.8299
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6486.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 134800195584 (Large Cap ($10B-$200B))
P/E ratio: 0.08206629211195421
Debt to equity: 0.2775
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6546.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5988640256 (Mid Cap ($2B-$10B))
P/E ratio: 0.14569943574667646
Debt to equity: 0.013600000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7111.T (annual, report date 2026-03-31)
Altman Z-score: 2.4992718241007177 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 34.39597315436241%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5615763546798034%
Free cash flow margin: -3.10126582278481%
Revenue growth: -2.4046317419976924%
Rule of 40 score: -5.505897564782503
Market cap: 3505542400 (Mid Cap ($2B-$10B))
P/E ratio: 0.504187029317012
Debt to equity: 0.7617
Free cash flow (dilution adjusted): -3678678.678678679
Operating income: 1301301.3013013012
Net income: 262762.7627627628
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7111.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3505542400 (Mid Cap ($2B-$10B))
P/E ratio: 0.504187029317012
Debt to equity: 0.7617
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7510.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 39362285568 (Large Cap ($10B-$200B))
P/E ratio: 0.08075648337709088
Debt to equity: 0.0331
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7932.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 33851166720 (Large Cap ($10B-$200B))
P/E ratio: 0.07636183174520869
Debt to equity: 0.2545
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8395.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 99884687360 (Large Cap ($10B-$200B))
P/E ratio: 0.05788812727450757
Debt to equity: 0.09684738098626065
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8395.T (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.32192306139749%
Capitalized R&D asset: 0
Free cash flow margin: -132.4692770784616%
Revenue growth: 17.805250983696432%
Rule of 40 score: -114.66402609476518
Market cap: 99884687360 (Large Cap ($10B-$200B))
P/E ratio: 0.05788812727450757
Debt to equity: 0.09684738098626065
Free cash flow (dilution adjusted): -499718468.4684685
Net income: 53709959.95995996
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 9502.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2265802866688 (Mega Cap (>= $200B))
P/E ratio: 0.05358651071041185
Debt to equity: 1.0985
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9502.T (annual, report date 2026-03-31)
Altman Z-score: 1.2536251560148026 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.973861915662713%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.6079284935589344%
Free cash flow margin: 9.431024627182822%
Revenue growth: -9.536655180359874%
Rule of 40 score: -0.10563055317705228
Market cap: 2265802866688 (Mega Cap (>= $200B))
P/E ratio: 0.05358651071041185
Debt to equity: 1.0985
Free cash flow (dilution adjusted): 2092267267.2672672
Operating income: 1439207957.957958
Net income: 1469275525.5255256
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AEO.L (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5850010 (Nano Cap (< $50M))
P/E ratio: 0.3082191780821918
Debt to equity: 0.1843
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AGBK (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.0637467767786335%
Capitalized R&D asset: 0
Free cash flow margin: -4.4098091178556125%
Revenue growth: -12.772680220199678%
Rule of 40 score: -17.18248933805529
Market cap: 1065134208 (Small Cap ($300M-$2B))
P/E ratio: 6.731481481481481
Debt to equity: 3.4078
Free cash flow (dilution adjusted): -11480418.250950571
Net income: 35462927.756653994
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for AGZI.L (quarterly, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 172668608 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AGZI.L (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 172668608 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AI.MC (annual, report date 2025-12-31)
Altman Z-score: 0.5115098765610084 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.766405584188952%
Free cash flow margin: -13.218928867800074%
Revenue growth: -3.562051425099513%
Rule of 40 score: -16.780980292899585
Market cap: 145004400 (Micro Cap ($50M-$300M))
Debt to equity: 0.42206459511035893
Free cash flow (dilution adjusted): -14617647.05882353
Operating income: -18282352.94117647
Net income: -29460000
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for AI.MC (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 145004400 (Micro Cap ($50M-$300M))
Debt to equity: 0.42206459511035893
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ALRS (quarterly, report date 2026-03-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.924659736125061%
Capitalized R&D asset: 0
Free cash flow margin: 33.35820597209823%
Revenue growth: 961.5134370579915%
Rule of 40 score: 994.8716430300897
Market cap: 821706752 (Small Cap ($300M-$2B))
P/E ratio: 21.999999999999996
Debt to equity: 0.5251516896847535
Free cash flow (dilution adjusted): 25035000
Net income: 22971000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for ALWIT.PA (annual, report date 2025-12-31)
Altman Z-score: 1.597073309956967 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.607317701623293%
Free cash flow margin: 4.407854366946206%
Revenue growth: -0.6934199425015408%
Rule of 40 score: 3.7144344244446654
Market cap: 12736492 (Nano Cap (< $50M))
Debt to equity: 0.5072
Free cash flow (dilution adjusted): 1014117.6470588236
Operating income: -494117.64705882355
Net income: -802352.9411764706
Long score: 4 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for ALWIT.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12736492 (Nano Cap (< $50M))
Debt to equity: 0.5072
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ARU.V (quarterly, report date 2025-12-31)
Altman Z-score: -343.7735249291495 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27774166 (Nano Cap (< $50M))
Debt to equity: -0.32281713464753536
Free cash flow (dilution adjusted): -926197.0802919706
Operating income: -13478472.99270073
Net income: -13759294.160583941
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ARU.V (annual, report date 2025-12-31)
Altman Z-score: -386.1072948196453 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27774166 (Nano Cap (< $50M))
Debt to equity: -0.32281713464753536
Free cash flow (dilution adjusted): -6557361.313868613
Operating income: -21004286.13138686
Net income: -22056767.883211676
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ASTL.TO (quarterly, report date 2026-03-31)
Altman Z-score: -0.2753362155190601 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -42.36111111111111%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.507587488386497%
Free cash flow margin: -11.013809363422029%
Revenue growth: -35.68614119693256%
Rule of 40 score: -46.69995056035459
Market cap: 641816704 (Small Cap ($300M-$2B))
Debt to equity: 2.7230000000000003
Free cash flow (dilution adjusted): -23525179.85611511
Operating income: -110431654.676259
Net income: -114676258.99280576
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BOCA.V (annual, report date 2021-12-31)
Altman Z-score: -20.06091597677029 (Distress Zone)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -124.0264105642257%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -123.03961584633853%
Rule of 40 score: 0
Market cap: 7592075 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -230640.94488188977
Operating income: -201755.90551181103
Net income: -203374.0157480315
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BXB.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 24990937088 (Large Cap ($10B-$200B))
P/E ratio: 15.522875816993466
Debt to equity: 0.8534
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BXB.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 24990937088 (Large Cap ($10B-$200B))
P/E ratio: 15.522875816993466
Debt to equity: 0.8534
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CAD.V (quarterly, report date 2026-04-30)
Altman Z-score: 4719.319948730205 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.7708835760792998%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.9409001892895916%
Rule of 40 score: 0
Market cap: 477772256 (Small Cap ($300M-$2B))
Debt to equity: 0.0007000000000000001
Free cash flow (dilution adjusted): -344626.27737226273
Operating income: -322037.95620437956
Net income: -301086.8613138686
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for CAN (quarterly, report date 2026-03-31)
Altman Z-score: -0.720346155370076 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -23.275416672130504%
Capitalized R&D asset: 22105709.30232558
ROCI (R&D adjusted): -11.789981460052406%
Rosenberg metric: -3.2569338432722703
Revenue growth: -68.3060376046048%
Rule of 40 score: -68.3060376046048
Market cap: 176386336 (Micro Cap ($50M-$300M))
Debt to equity: 0.1481
Operating income: -42256589.14728682
Net income: -68796899.2248062
Long score: 2 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CHC.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10525817856 (Large Cap ($10B-$200B))
P/E ratio: 10.965219421101772
Debt to equity: 0.1804
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CHC.AX (annual, report date 2025-06-30)
Altman Z-score: 8.29644832771208 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.886836027713628%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.483216117441111%
Free cash flow margin: 80.23518769787427%
Revenue growth: -12.82336381164168%
Rule of 40 score: 67.41182388623258
Market cap: 10525817856 (Large Cap ($10B-$200B))
P/E ratio: 10.965219421101772
Debt to equity: 0.1804
Free cash flow (dilution adjusted): 231895424.83660132
Operating income: 137973856.2091503
Net income: 214183006.5359477
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for DEFT (quarterly, report date 2026-03-31)
Altman Z-score: 0.17511340195123068 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.218114631172294%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.545411828650363%
Free cash flow margin: -26.721101255892204%
Rule of 40 score: -26.721101255892204
Market cap: 153063760 (Micro Cap ($50M-$300M))
P/E ratio: 6.875
Debt to equity: 0.019
Free cash flow (dilution adjusted): -345997.12230215827
Operating income: 4043671.9424460432
Net income: 3547984.8920863313
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for DNA (quarterly, report date 2026-03-31)
Altman Z-score: -7.783096489972755 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.189772580289276%
Capitalized R&D asset: 106391580
ROCI (R&D adjusted): -7.3518969785628805%
Rosenberg metric: -0.1938875256847607
Free cash flow margin: -331.0670637773442%
Revenue growth: -41.687627260749785%
Rule of 40 score: -372.75469103809394
Market cap: 480788256 (Small Cap ($300M-$2B))
Debt to equity: 0.9268000000000001
Free cash flow (dilution adjusted): -64472000
Operating income: -71374000
Net income: -82587000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DTE (quarterly, report date 2026-03-31)
Altman Z-score: 0.6888009219772084 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.917709667882133%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.819834448889065%
Free cash flow margin: -6.28282435323867%
Revenue growth: 16.102077687443543%
Rule of 40 score: 9.819253334204873
Market cap: 31091914752 (Large Cap ($10B-$200B))
P/E ratio: 23.66557911908646
Debt to equity: 2.1879
Free cash flow (dilution adjusted): -323000000
Operating income: 414000000
Net income: 247000000
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for FPG.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8041535 (Nano Cap (< $50M))
Debt to equity: 3.7141
Long score: 0 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for FPG.PA (annual, report date 2025-12-31)
Altman Z-score: 1.340757567224446 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -20.028050490883587%
Free cash flow margin: -6.873296688068733%
Revenue growth: 17.46641986124259%
Rule of 40 score: 10.593123173173854
Market cap: 8041535 (Nano Cap (< $50M))
Debt to equity: 3.7141
Free cash flow (dilution adjusted): -1750588.2352941176
Operating income: -840000
Net income: -785882.3529411765
Long score: 0 | Short score: 12
Recommendation: Short
Stock screener scorecard for GG8.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 216132640 (Micro Cap ($50M-$300M))
Debt to equity: 0.0009
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HMAAGRO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.2653422914463306 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.7265183086247207%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.464460398700504%
Revenue growth: -27.053989346563544%
Rule of 40 score: -27.053989346563544
Market cap: 10686427136 (Large Cap ($10B-$200B))
P/E ratio: 0.06923728666802212
Debt to equity: 0.8832
Operating income: -1504345.0614667232
Net income: 871237.8126324714
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for HTCO (annual, report date 2025-10-31)
Altman Z-score: 3.867964530452874 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -254.44779701396888%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -157.68300420271876%
Free cash flow margin: -8.066292206895541%
Revenue growth: 101.25836021285801%
Rule of 40 score: 93.19206800596247
Market cap: 28004744 (Nano Cap (< $50M))
Debt to equity: 0.2084
Free cash flow (dilution adjusted): -13304164.615384616
Operating income: -15317103.846153846
Net income: -15469559.23076923
Long score: 6 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for HTCO (quarterly, report date 2025-10-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 28004744 (Nano Cap (< $50M))
Debt to equity: 0.2084
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IDFCFIRSTB.NS (annual, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.643459154560063%
Capitalized R&D asset: 0
Free cash flow margin: 20.761007296831075%
Revenue growth: 0.37991943779160653%
Rule of 40 score: 21.14092673462268
Market cap: 696159633408 (Mega Cap (>= $200B))
P/E ratio: 0.326795570906587
Debt to equity: 0.7727783905977178
Free cash flow (dilution adjusted): 640021195.4217889
Net income: 170682492.58160236
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IDFCFIRSTB.NS (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.699557698593966%
Capitalized R&D asset: 0
Revenue growth: -8.73682141259488%
Rule of 40 score: -8.73682141259488
Market cap: 696159633408 (Mega Cap (>= $200B))
P/E ratio: 0.326795570906587
Debt to equity: 0.7727783905977178
Net income: 35040271.301398896
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for KUST (quarterly, report date 2026-03-31)
Altman Z-score: -10.768555018886453 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 286009.03
ROCI (R&D adjusted): -13.014435600190478%
Rosenberg metric: 10.967943958642689
Free cash flow margin: -32.399896528609005%
Rule of 40 score: -32.399896528609005
Market cap: 846261 (Nano Cap (< $50M))
Debt to equity: 0.4861
Free cash flow (dilution adjusted): -1397808
Operating income: -1296987
Net income: -5885315
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for METCB (quarterly, report date 2026-03-31)
Altman Z-score: 0.9235672048568299 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.468608982984137%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.4792216641437532%
Free cash flow margin: -47.14463091939184%
Revenue growth: -4.995039333786433%
Rule of 40 score: -52.13967025317827
Market cap: 474811264 (Small Cap ($300M-$2B))
Debt to equity: 1.0728
Free cash flow (dilution adjusted): -57334000
Operating income: -24305000
Net income: -18319000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MLAZR.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 9176813 (Nano Cap (< $50M))
Debt to equity: 2.3069944198639867
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for MLAZR.PA (annual, report date 2025-12-31)
Altman Z-score: -0.56165406022663 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.450780207830852%
Free cash flow margin: 23.948293060227456%
Revenue growth: 34.88672617647752%
Rule of 40 score: 58.83501923670497
Market cap: 9176813 (Nano Cap (< $50M))
Debt to equity: 2.3069944198639867
Free cash flow (dilution adjusted): 1842438.8235294118
Operating income: -1573089.411764706
Net income: -5453563.529411765
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MTG.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 353545536 (Small Cap ($300M-$2B))
P/E ratio: 34.93486094428531
Debt to equity: 0.22920000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MYE.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 138892576 (Micro Cap ($50M-$300M))
P/E ratio: 10.457516339869281
Debt to equity: 0.0509
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PHX.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 73273048 (Micro Cap ($50M-$300M))
Debt to equity: 0.0462
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for PHX.AX (annual, report date 2025-06-30)
Altman Z-score: 9.749732864835675 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: -294660.8648227503
ROCI (R&D adjusted): -9.38065097923153%
Free cash flow margin: -135.02732240437157%
Revenue growth: 10.628496812629768%
Rule of 40 score: -124.39882559174181
Market cap: 73273048 (Micro Cap ($50M-$300M))
Debt to equity: 0.0462
Free cash flow (dilution adjusted): -6460130.718954248
Operating income: -930065.3594771242
Net income: -172549.01960784313
Long score: 4 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for PIN.L (quarterly, report date 2025-11-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1536458752 (Small Cap ($300M-$2B))
Debt to equity: 0.11207294643889885
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RBN.L (annual, report date 2025-12-31)
Altman Z-score: 2.913796336139563 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.453180033197039%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.793193143000407%
Free cash flow margin: 1.5869062444404909%
Revenue growth: 7.724813982569692%
Rule of 40 score: 9.311720227010184
Market cap: 21360642 (Nano Cap (< $50M))
P/E ratio: 0.11293436293436292
Debt to equity: 0.3125
Free cash flow (dilution adjusted): 1205405.4054054052
Operating income: 4654054.054054054
Net income: 3079729.7297297297
Long score: 7 | Short score: 1
Recommendation: Neutral